First-trimester screening: An overview

Journal of Histochemistry and Cytochemistry

Volumn 53, Issue 3, 2005, Pages 281-283

  Eiben, Bernd ^a,b   Glaubitz, Ralf ^a  

^a Stibbe and Partners   (Germany)

^b Institute of Clinical Genetics   (Germany)

Author keywords

Chromosomal aberrations; First trimester screening; Free hCG; Heart defects; Maternal age; Nasal bone; NT; PAPP A; Sonography; Trisomy 21

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

AMNIOCENTESIS; CHROMOSOME ABERRATION; COMPUTER PROGRAM; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; DIAGNOSTIC ACCURACY; DOWN SYNDROME; EMBRYO; FACIAL BONE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; MATERNAL AGE; MATERNAL BLOOD; MONOSOMY X; PRENATAL SCREENING; PRIORITY JOURNAL; RISK FACTOR; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TRISOMY 21;

AGE FACTORS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME ABERRATIONS; DOWN SYNDROME; FEMALE; HUMANS; NASAL BONE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 14844335722     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4B6420.2005     Document Type: Conference Paper

References (13)

1. Cicero S, Curcio P, Papageorhiou A, Sonek J, Nicolaides KH (2001) Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation. Lancet 358:1665-1667
2. Cuckle H (1999) Maternal age-standardisation of prevalence of Down's syndrome. Lancet 354:529-530
3. Eiben B, Alkier R, Denk R, Ellis A, Grunow G, Hackeloer B-J, Wagner H (2002a) On the perinatal risk precision in the first trimester of pregnancy in relation to nuchal translucency and biochemical analysis of maternal serum. Clin Lab 48:421-423
4. Eiben B, Hackelöer B-J, Huesgen G, Kozlowski P, Merz E, Osmers R, Wagner H (2002b) Pranatale Risikopräzisierung im ersten Trimenon der Schwangerschaft über Messung der fetalen Nacken-transparenz und biochemischer Analyse aus dem maternalen Serum. Ikon 11:2-8
5. Eiben B, Hammans W, Keuter S, Goebel R, Louwen F, Epplen JT (2001) Eine klinische Studie zur Wertigkeit der Trisomie 21. Risikopräzisierung im ersten Trimester der Schwangerschaft. Zeitschr Geburtsh Neonatol 205:94-98
6. Hyett JA, Perdu M, Sharland GK, Snijders RJM, Nicolaides KH (1999) Using fetal nuchal translucency to screen for congenital cardial defects at 10-14 weeks of gestation: population based cohort study. Br Med J 318:81-85
7. Nicolaides KH (2003) Screening for chromosomal defects. Ultrasound Obstet Gynecol 21:313-321
8. Nicolaides KH, Sebire NJ, Snijders JM (1999) The 11-14-week Scan. The Diagnosis of Fetal Abnormalities. New York, London, The Parthenon Publishing Group
9. Schulte-Valentin M, Schindler H (1992) Non-echogenic nuchal oedema as a marker for trisomy 21 screening. Lancet 339:1053
10. Spencer K, Heath V, Flack N, Ong C, Nicolaides KH (2000a) First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21. Prenat Diagn 20:635-639
11. Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH (2000b) Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 20:495-499
12. Spencer K, Ong C, Skentou H, Liao AW, Nicolaides KH (2000c) Screening for trisomy 13 by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 20:411-416
13. Spencer K, Tul N, Nicolaides KH (2000d) Maternal serum free β-hCG and PAPP-A in fetal sex chromosome defects in the first trimester. Prenat Diagn 20:390-394